BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Mark Massaro has maintained a Buy rating on Sophia Genetics (NASDAQ:SOPH) and increased the price target from $7 to $8.
March 06, 2024 | 6:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BTIG analyst Mark Massaro maintains a Buy rating on Sophia Genetics and raises the price target from $7 to $8.
The increase in the price target by a reputable analyst suggests a positive outlook on the company's future performance, which could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100